A pioneering clinical trial is exploring whether lab-engineered stem cells can restore dopamine production in people with Parkinson’s disease. In Parkinson’s disease, the problem starts deep in the brain, where a small group of cells gradually fails. The condition is progressive and affects more than one million people in the United States, with roughly 90,000 [...]from SciTechDaily https://ift.tt/OXfnAW0
